Surgical technology developer Integra LifeSciences has obtained US Food and Drug Administration (FDA) approval to use its Camino Flex Ventricular Catheter in magnetic resonance imaging (MRI) scans.

The advanced, tunnelled ventricular catheter, which is MR conditional at 1.5 T and 3.0 T, features a sensor to measure directly at the source, and is used with Integra’s next-generation Camino Monitor, which debuted in 2013.

The new Camino platform includes the Integra Camino intracranial pressure and temperature monitor and Integra Camino Flex ventricular catheter, which uses strain gauge technology.

“MRI scans for patients receiving neuromonitoring are becoming more prevalent, and patients implanted with Integra’s Camino Flex Ventricular Catheter can now safely undergo MRI scans without the need to remove the catheter.”

The Camino Flex Ventricular Catheter provides clinicians access to a truly advanced system for the diagnosis and treatment of compromised neurological conditions, when coupled with the Camino Monitor.

According to Integra, around 800 centres in the US use Camino platform for conditions that cause an elevated intracranial pressure, including traumatic brain injury, subarachnoid haemorrhage and strokes.

Integra vice-president of marketing for neurosurgery Peter Ligotti said: “MRI scans for patients receiving neuromonitoring are becoming more prevalent, and patients implanted with Integra’s Camino Flex Ventricular Catheter can now safely undergo MRI scans without the need to remove the catheter.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

“This is especially beneficial for neuro patients whose management includes both CSF drainage and follow-up MRI.”

In contrast to other tunnelled ventricular catheters that depend upon cerebrospinal fluid flow to measure intracranial pressure, the company’s Camino Flex Ventricular Catheter is designed to continuously monitor intracranial pressure independently in the ventricles, even when cerebrospinal fluid flow cannot be established.

A multilumen design also allows for simultaneous cerebrospinal fluid drainage and intracranial pressure monitoring, providing uninterrupted measurement of patient pressure.